PRKAB1 and hepatocellular carcinoma: NOD2 is reported to activated NF-κB and MAPK pathways in macrophages and certain types of cancers46,48, however in HCC cells, NOD2 mainly activated AMPK pathway and exerted its anti-tumor effect through AMPK pathway.